Netherlands· NL-3070755f8e33
Flixonase 50 microgram per dosis, neusspray suspensie
A fluticasone product containing fluticasonpropionaat, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Fluticasone is registered in 14 of 19 countries.
Countries holding a registration under ATC R01AD08 (fluticasone), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Fluticasone · ATC R01AD08
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FLUTICASONPROPIONAAT
- Manufacturer
- Euro Registratie Collectief B.V.
- Country
- Netherlands (NL)
- ATC code
- R01AD08
- ATC class
- Fluticasone
- Defined daily dose
- 0.2 mg, N
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id126706//14424
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for fluticasone.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fluticasone · interactions on record
55 records
- 29 severe
- 25 moderate
- 1 minor
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- KetoconazoleH02CA03severe
- TroleandomycinJ01FA08severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fluticasone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainFLIXONASE 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASALGlaxosmithkline (Ireland) Limited
- FinlandFlixonaseParanova Oy
- United StatesFluticasone PropionateAdvagen Pharma Ltd.
- IrelandFlixonase Allergy Relief 50 micrograms per dose Nasal SprayHaleon Ireland Limited
- PolandFaniposTeva Pharmaceuticals Polska Sp. z o.o.
- SwitzerlandNasofan, Nasenspray, SuspensionMepha Pharma AG
- United KingdomAvamys 27.5micrograms/dose nasal sprayGlaxoSmithKline UK Ltd
- BelgiumAerivio Spiromax 50 µg - 500 µgTeva
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Flixonase Aquosum, Flixotide Diskus Forte
- Belgium · Flixonase Aqua, Flixotide
- Bulgaria · Аркуист, Фликсоназе
- Cyprus · Cutivate, Flixonase Aqueous
- Czechia · Flixotide Diskus, Flixotide Inhaler N
- Germany · Flutica, Fluticason Cipla
- Denmark · Flixotide, Flurhin
- Estonia · Cutivate Cream, Flixonase
- Spain · Avancort, Flixonase
- Finland · Flixonase, Flixotide Diskus
- France · Fixorinox, Flixonase
- United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
- Greece · Alerxem, Bocacort-S
- Croatia · Flixonase, Flixotide Inhaler
- Hungary · Cutivate, Flixonase
- Ireland · Arquist, Flixonase Allergy Relief
- Iceland · Avamys, Flixotide
- Italy · Aktanos, Deflut
- Liechtenstein · Avamys
- Lithuania · Cutivate, Flixotide
- Luxembourg · Flixonase Aqua, Flixotide
- Latvia · Flixonase, Flixotide
- Malta · Cutivate, Flihaler
- Norway · Avamys, Flurhin
- Poland · Cutivate, Fanipos
- Portugal · Brisovent Diskus, Brisovent Inalador
- Romania · Arquist, Cutivate
- Sweden · Arquist, Fluticasone Cipla
- Slovenia · Flixonase, Flixotide
- Slovakia · Flixonase Aqueous, Flixotide Diskus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4618e09-5fd1-4147-b6cc-5176c8230e8b GET /v1/drugs/f4618e09-5fd1-4147-b6cc-5176c8230e8b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Neusspray, suspensie",
"route": "Nasaal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h14424_smpc.pdf",
"strength": null,
"atc_label": "Fluticasone",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg126706",
"excipients": [
"BENZALKONIUMCHLORIDE",
"CARMELLOSE NATRIUM (E 466)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"FENETHYLALCOHOL",
"GLUCOSE 0-WATER",
"POLYSORBAAT 80 (E 433)",
"WATER, GEZUIVERD",
"ZOUTZUUR (E 507)"
],
"substances": [
"FLUTICASONPROPIONAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h126706.pdf",
"authorised_at": "2020/06/10",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "126706//14424",
"additional_monitoring": "N"
}See everything about fluticasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.